ZBTB33 and colonic neoplasm: As a dual-specificity DNA-binding transcription factor, Kaiso functions as either a transcriptional activator or repressor (Daniel, 2007; Iioka et al., 2009; Pierre et al., 2019), which further adds to the complexity of its role in normal vertebrate development and disease states such as IBD and colon cancer.